blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2058311

EP2058311 - 8-[3-amino-piperidin-1-yl]-xanthins, their production and utilisation as medicine [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  04.01.2019
Database last updated on 22.05.2024
FormerGrant of patent is intended
Status updated on  13.03.2018
FormerExamination is in progress
Status updated on  14.03.2017
Most recent event   Tooltip04.01.2019Application deemed to be withdrawnpublished on 06.02.2019  [2019/06]
Applicant(s)For all designated states
Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[2009/20]
Inventor(s)01 / Himmelsbach, Dr. Frank
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Ahornweg 16
88441 MITTELBIBERACH / DE
02 / Langkopf, Dr. Elke
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Schloss 3
88447 WARTHAUSEN / DE
03 / Eckhardt, Dr. Matthias
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Kirschenweg 7
88400 BIBERACH / DE
04 / Mark, Dr. Michael
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Hugo-Haering-Str. 50
88400 BIBERACH / DE
05 / Maier, Dr. Roland
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Bodelschwinghstr. 39
88400 BIBERACH / DE
06 / Lotz, Dr. Ralf
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Schluesslerstr. 28
88433 SCHEMMERHOFEN / DE
07 / Tadayyon, Dr. Mohammad
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
6, Bridges Court
St. Andrew Street
HERTFORD, SG14 1HQ / GB
[N/P]
Former [2009/20]01 / Himmelsbach, Dr. Frank
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Ahornweg
88441, MITTELBIBERACH / DE
02 / Langkopf, Dr. Elke
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Schloss
88447, WARTHAUSEN / DE
03 / Eckhardt, Dr. Matthias
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Kirschen
88400, BIBERACH / DE
04 / Mark, Dr. Michael
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Hugo-Hae
88400, BIBERACH / DE
05 / Maier, Dr. Roland
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Bodelsch
88400, BIBERACH / DE
06 / Lotz, Dr. Ralf
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Schluess
88433, SCHEMMERHOFEN / DE
07 / Tadayyon, Dr. Mohammad
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG 6, Bridg
HERTFORD, SG14 1HQ / GB
Representative(s)Simon, Elke Anna Maria, et al
Boehringer Ingelheim GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[2012/40]
Former [2009/48]Hammann, Heinz
Boehringer Ingelheim GmbH CD-Patents Binger Straße 173
55216 Ingelheim am Rhein / DE
Former [2009/20]Hammann, Heinz
Boehringer Ingelheim GmbH Binger Strasse 173
55216 Ingelheim am Rhein / DE
Application number, filing date08159140.618.08.2003
[2009/20]
Priority number, dateDE2002103824321.08.2002         Original published format: DE 10238243
DE2003101235320.03.2003         Original published format: DE 10312353
[2009/20]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report 
No.:EP2058311
Date:13.05.2009
Language:DE
[2009/20]
Type: A3 Search report 
No.:EP2058311
Date:13.04.2011
[2011/15]
Search report(s)(Supplementary) European search report - dispatched on:EP14.03.2011
ClassificationIPC:C07D413/04, C07D473/04
[2018/11]
CPC:
A61K9/2866 (EP); C07D473/04 (EP,CN,KR); A61K47/02 (EP);
A61K9/0095 (EP); A61K9/02 (EP); A61K9/2018 (EP);
A61K9/4858 (EP); A61P1/02 (EP); A61P1/04 (EP);
A61P1/18 (EP); A61P11/00 (EP); A61P13/08 (EP);
A61P13/12 (EP); A61P15/00 (EP); A61P15/08 (EP);
A61P15/16 (EP); A61P17/00 (EP); A61P17/06 (EP);
A61P19/00 (EP); A61P19/02 (EP); A61P19/08 (EP);
A61P19/10 (EP); A61P25/00 (EP); A61P25/06 (EP);
A61P25/16 (EP); A61P25/22 (EP); A61P25/24 (EP);
A61P25/28 (EP); A61P27/02 (EP); A61P29/00 (EP);
A61P3/00 (EP); A61P3/04 (EP); A61P3/06 (EP);
A61P3/08 (EP); A61P3/10 (EP); A61P3/12 (EP);
A61P31/10 (EP); A61P31/12 (EP); A61P31/18 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P35/04 (EP);
A61P37/06 (EP); A61P43/00 (EP); A61P5/06 (EP);
A61P5/14 (EP); A61P7/00 (EP); A61P7/10 (EP);
A61P9/10 (EP); A61P9/12 (EP); C07D473/06 (CN);
C07D473/12 (KR) (-)
Former IPC [2009/20]C07D473/04, A61K31/522, A61P3/10
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2009/20]
Extension statesLT13.10.2011
LV13.10.2011
TitleGerman:8-[3-amino-piperidin-1-yl]-xanthine, deren Herstellung und deren Verwendung als Arzneimittel[2009/20]
English:8-[3-amino-piperidin-1-yl]-xanthins, their production and utilisation as medicine[2009/20]
French:8-[3-amino-pipéridine-1-yl]-xanthine, leur fabrication et leur utilisation en tant que médicament[2009/20]
Examination procedure13.10.2011Examination requested  [2011/47]
27.01.2012Amendment by applicant (claims and/or description)
02.11.2012Despatch of a communication from the examining division (Time limit: M06)
19.08.2013Reply to a communication from the examining division
03.03.2015Despatch of a communication from the examining division (Time limit: M06)
10.09.2015Reply to a communication from the examining division
04.03.2016Despatch of a communication from the examining division (Time limit: M06)
14.09.2016Reply to a communication from the examining division
03.03.2017Despatch of a communication from the examining division (Time limit: M06)
11.09.2017Reply to a communication from the examining division
14.03.2018Communication of intention to grant the patent
24.07.2018Fee for grant paid
24.07.2018Fee for publishing/printing paid
25.07.2018Application deemed to be withdrawn, date of legal effect  [2019/06]
17.09.2018Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2019/06]
Parent application(s)   TooltipEP03792359.6  / EP1532149
Divisional application(s)EP18185103.1  / EP3424926
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20030792359) is  27.10.2005
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
19.08.2013Request for further processing filed
19.08.2013Full payment received (date of receipt of payment)
Request granted
05.09.2013Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
27.01.2012Request for further processing filed
27.01.2012Full payment received (date of receipt of payment)
Request granted
09.02.2012Decision despatched
Fees paidRenewal fee
27.10.2008Renewal fee patent year 03
27.10.2008Renewal fee patent year 04
27.10.2008Renewal fee patent year 05
27.10.2008Renewal fee patent year 06
31.08.2009Renewal fee patent year 07
31.08.2010Renewal fee patent year 08
31.08.2011Renewal fee patent year 09
31.08.2012Renewal fee patent year 10
02.09.2013Renewal fee patent year 11
01.09.2014Renewal fee patent year 12
31.08.2015Renewal fee patent year 13
31.08.2016Renewal fee patent year 14
31.08.2017Renewal fee patent year 15
31.08.2018Renewal fee patent year 16
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]DE2705025  (INTERX RESEARCH CORP) [Y] 1,5,18-22 * Formel (I); page 6 - page 9; claims 1-14 *;
 [A]EP0149578  (ADIR [FR]) [A] 1-22 * Ansprüche 1-12; Formel (I); Beispiel 12 *;
 [Y]US4968672  (JACOBSON KENNETH A [US], et al) [Y] 1,5,18-22 * the whole document *;
 [A]WO9107945  (LVMH RECH [FR]) [A] 1-22 * Ansprüche 1-28; Formel (I); Seite 4, Zeile 28 *;
 [Y]WO9967279  (PROBIODRUG GES FUER ARZNEIM [DE], et al) [Y] 1,5,18-22 * the whole document *;
 [Y]WO0202560  (NOVO NORDISK AS [DK], et al) [Y] 1-22 * Ansprüche 1-53; Formel (I);; page 39, line 19 - line 26 *;
 [XP]WO02068420  (BOEHRINGER INGELHEIM PHARMA [DE], et al) [XP] 1-22 * Ansprüche 1-18; Formel (I); Verbindungen (344),(471), (343), (439), (136), (528), (521), (520), (444), (524), (368), (525), (329)-(333), (361), (523), (482), (428), (138) und (469) *;
 [XP]WO03004496  (NOVO NORDISK AS [DK]) [XP] 1-22 * Ansprüche 1-55; Formel (I); Beispiele 1,9-10,16-74,87-103; page 21, line 29 - line 34 *;
 [YP]WO03024965  (NOVO NORDISK AS [DK], et al) [YP] 1-22 * Ansprüche 1-59; Formel (II); Beispiele; page 21, line 30 - line 35 *;
 [XP]WO03057200  (NOVO NORDISK AS [DK], et al) [XP] 1-22 * Ansprüche 1-18; Formel (I); Beispiele 1,9-10, Seite 3, Zeile 16-20; Seite 33, Zeile 16-21 *;
 [Y]  - ROLAND SAUER ET AL, "Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A2A-selective adenosine receptor antagonists", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, US, (20000101), vol. 43, no. 3, doi:10.1021/JM9911480, ISSN 0022-2623, pages 440 - 448, XP002389734 [Y] 1,5,18-22 * the whole document *

DOI:   http://dx.doi.org/10.1021/jm9911480
 [Y]  - BUNDGAARD H, "Design of Prodrugs: BIOREVERSIBLE DERIVATIVES FOR VARIOUS FUNCTIONAL GROUPS AND CHEMICAL ENTITIES", DESIGN OF PRODRUGS, XX, XX, (19850101), pages 1 - 92, XP002247460 [Y] 1,5,18-22 * the whole document *
by applicantWO9846576
    - N.M. NIELSEN ET AL., INTERNATIONAL JOURNAL OF PHARMACEUTICS, (1987), vol. 39, pages 75 - 85
    - ALLINGER N. L.; ELIEL E. L., Topics in Stereochemistry, WILEY INTERSCIENCE, (1971), vol. 6
    - PROC. NATL. ACAD. SCI., (1993), vol. 90, pages 5757 - 5761
    - KIMURA ET AL., CHEM. PHARM. BULL., (1982), vol. 30, pages 552 - 558
    - R. BESSE ET AL., TETRAHEDRON, (1990), vol. 46, pages 7803 - 7812
    - GONSALVES ET AL., TETRAHEDRON, (1992), vol. 48, page 6821
    - SAGI ET AL., HETEROCYCLES, (1989), vol. 29, page 2253
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.